Viking Therapeutics Inc (NASDAQ:VKTX)

5.39
Delayed Data
As of Nov 26
 -0.28 / -4.94%
Today’s Change
4.95
Today|||52-Week Range
10.09
-4.26%
Year-to-Date

Today’s Trading

Previous close5.67
Today’s open5.57
Day’s range5.34 - 5.65
Volume21,010
Average volume (3 months)613,347
Market cap$421.7M
Data as of 1:00pm ET, 11/26/2021

Growth & Valuation

Earnings growth (last year)-51.87%
Earnings growth (this year)-36.70%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
ABUSArbutus Biopharma Co...-0.06-1.72%
ZOMZomedica Corp-0.01-2.37%
TCDATricida Inc-0.28-3.64%
CLVSClovis Oncology Inc-0.12-3.59%
Data as of 1:00pm ET, 11/26/2021

Financials

Next reporting dateMarch 9, 2022
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$39.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts